Comment Print Reprint Email

Array BioPharma's CEO Presents At Morgan Stanley Healthcare Conference - Transcript

BY Seeking Alpha | 09/10/12 - 04:29 PM EDT

Stock quotes in this article: ARRY

Comment

Link

Find out if (ARRY) is in Cramer's Portfolio.

Array BioPharma, Inc. (ARRY)

Morgan Stanley Healthcare Conference

September 10, 2012, 10:35 a.m. ET

Executives

Ron Squarer - CEO

Michael Carruthers - CFO

Kevin Kock - President and CSO

Presentation

Unidentified Analyst

Compare to:
Previous Statements by ARRY
» Array BioPharma's CEO Discusses F4Q2012 Results - Earnings Call Transcript
» Array BioPharma CEO Discusses F1Q2011 Results - Earnings Call Transcript
» Array BioPharma Inc. F4Q10 (Qtr End 06/30/10) Earnings Call Transcript

Okay. I think we will go ahead and get started here. For those of you who don't know me, I'm (inaudible) MOS Biotech team and I'm joined right now by the team from Array BioPharma. So, we have Ron Squarer, CEO; Michael Carruthers, CFO; and Kevin Kock, CSO of Array. Thank you guys for joining us. Few housekeeping things before we get started. All disclosures, personal holding disclosures and Morgan Stanley disclosures are in the Morgan Stanley website. MorganStanley.com/researchdisclosures. For those of you who haven't been here before this is open Q&A, if you are free to join us at any point if you have a question.

With that I'll turn it over to Ron and team and guys you have a lot of drugs in development a lot of stuff going on, so maybe to start if you could just give us some brief overview of the company and their drugs in recent events.

Ron Squarer

Thank you for that introduction, I'm going to be making some forward-looking statements, so please consult our 10-K for a full discussion of risk and get specifically Kevin Kock, our Chief Scientific Officer here also one of the founders of the company, Mike Carruthers, our CFO, we also in the audience have another one of our Founders and our Chairman, Kyle Lefkoff.

So, it has been a very exciting time indeed. We are about over 160% year-to-date, over 60% in the last three months, in terms of our share price and this is really been catalyzed by their progress we have made with our portfolio looking at as many as five potential Phase 3 starts between now and the end of next year.

1 2 3 Next › Last »

Select the service that is right for you!

COMPARE ALL SERVICES

Action Alerts PLUS

TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:

$2.5+ million portfolio
Large-cap and dividend focus
Intraday trade alerts from Cramer
Weekly roundups

Dividend Stock Advisor

TRY IT FREE

New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:

Diversified model portfolio of dividend stocks
Alerts when market news affect the portfolio
Bi-weekly updates with exact steps to take - BUY, HOLD, SELL

Stocks Under $10

TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:

Model portfolio
Stocks trading below $10
Intraday trade alerts
Weekly roundups

Real Money

TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:

Jim Cramer + 20 Wall Street pros
Intraday commentary & news
Real-time trading forum
Actionable trade ideas

Real Money Pro

TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:

Real Money + Doug Kass + 15 more Wall Street Pros
Intraday commentary & news
Ultra-actionable trading ideas

Options Profits

TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:

100+ monthly options trading ideas
Actionable options commentary & news
Real-time trading community
Options TV

To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.